16 November 2009
Carcinoid heart disease as a first manifestation of midgut carcinoid tumor in a young woman
Andrzej Tomaszewski, Beata Matuszek, Tomasz Zapolski, Elżbieta Czekajska-Chehab, Mariusz Matuszek, Sławomir RudzkiAm J Case Rep 2009; 10:193-197 :: ID: 878251
Abstract
Background: The most common neuroendocrine tumor (NET) of the gastroenteropancreatic axis is a midgut carcinoid tumor producing serotonin, which is characterized by slow growth but high malignancy potential. The tumor is commonly asymptomatic until it becomes large or has metastasized. Up to 10% of the patients develop carcinoid syndrome due to the release of tumor secretions into the systemic circulation, avoiding the portal circulation. Clinically, this is characterized by hot flushes, diarrhea, bronchospasm, and carcinoid heart disease at diagnosis in approximately 50% of the patients with carcinoid syndrome, but only in 10‑20% is this the first clinical symptom of the syndrome.
Case Report: The case of a 34-year-old woman with carcinoid heart disease in the course of carcinoid syndrome as the first clinical symptom of midgut carcinoid tumor is presented. This unusual course of the clinical picture significantly prolonged and hindered the diagnostic process. However, extensive surgical, cardiologic, and endocrinological treatment was successful. One-year, two-year, and five-year follow-ups showed improved heart function and no signs of tumor relapse.
Conclusions: Even though heart disease coexists with other symptoms typical of carcinoid syndrome, it should be borne in mind that right-sided heart failure could be the first sign of the disease. Echocardiography is the investigation of choice, revealing a unique valvular appearance at diagnosis, and should be performed at the time of diagnosing serotonin-producing NET. Multidisciplinary management (surgical and medical) could improve prognosis and the quality of life of the patients.
Keywords: midgut carcinoid tumor, Carcinoid Heart Disease, valvular dysfunction
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945852
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.944817
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946074
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946165
Most Viewed Current Articles
21 Jun 2024 : Case report
89,036
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
50,209
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
25,680
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
22,688
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030